Compare PTCT & VIPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | VIPS |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.7B |
| IPO Year | 2006 | 2012 |
| Metric | PTCT | VIPS |
|---|---|---|
| Price | $76.82 | $14.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 4 |
| Target Price | ★ $80.65 | $19.58 |
| AVG Volume (30 Days) | 1.5M | ★ 2.4M |
| Earning Date | 05-07-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 4.38% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $3.79 |
| Revenue Next Year | $17.70 | $2.05 |
| P/E Ratio | ★ N/A | $9.00 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $43.18 | $12.65 |
| 52 Week High | $90.87 | $21.08 |
| Indicator | PTCT | VIPS |
|---|---|---|
| Relative Strength Index (RSI) | 43.24 | 55.51 |
| Support Level | $74.45 | $14.08 |
| Resistance Level | $79.67 | $15.03 |
| Average True Range (ATR) | 3.27 | 0.36 |
| MACD | -1.01 | 0.08 |
| Stochastic Oscillator | 4.47 | 63.27 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts of 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurement, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners. As of March 31, 2025, Eric Ya Shen, chair and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds a 12.5% interest.